Induction of the P21/CDK6 Pathway and Alteration of the Immune Microenvironment by the Stem Cell Marker CBX3 in Melanoma

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2025 Feb 11

PMID 39934923

Authors

Wanxian Chen

Linsa Zhou

Jingjing Jiang

Jiasheng Chen

Deyi Geng

Yaokun Chen

Xiaosha Han

Qihu Xie

Genghong Guo

Xuefen Chen

Shijie Tang

Xiaoping Zhong

Affiliations

Soon will be listed here.

Abstract

Background: As one of the stem cell markers, chromobox protein homolog 3 (CBX3) participates in multiple signaling pathways that affect the progression of various tumors. However, the role of CBX3 in melanoma remains unclear, and the mechanisms by which CBX3 may regulate immunotherapy outcome remain largely unknown.

Methods: We used the Cancer Genome Atlas, Genotype-Tissue Expression portal, and Gene Expression Omnibus database to estimate CBX3 expression and its prognostic effect in melanoma. The role of CBX3 in proliferation and migration of melanoma cells were examined using the CCK8, cloning, wound healing, and transwell assays. The effect of CBX3 on melanoma tumorigenesis was assessed using an in vivo animal model. The role of CBX3 in cell cycle was examined using flow cytometry, and expression levels of cell cycle-related genes and proteins in cells with altered CBX3 levels were analyzed using qPCR and western blotting. The function of CBX3 in the immune microenvironment of melanoma was studied using single-cell RNA sequencing and public databases.

Results: We found that CBX3 was highly expressed in melanoma with poor prognosis. CBX3 promoted the proliferation and migration of melanoma cells in vivo and in vitro. Functional analysis revealed that CBX3 regulates cell cycle, as it accelerated the G1 to S transition, decreased p21 expression, and increased CDK6 expression. Finally, single-cell sequencing and immune-related assays showed that CBX3 is immunogenic and can change the immune microenvironment of melanoma.

Conclusions: We conclude that the stem cell marker, CBX3 activates the p21/CDK6 pathway and alters the immune microenvironment in melanoma.

References

Kalaora S, Nagler A, Wargo J, Samuels Y . Mechanisms of immune activation and regulation: lessons from melanoma. Nat Rev Cancer. 2022; 22(4):195-207. DOI: 10.1038/s41568-022-00442-9. View

Newman A, Liu C, Green M, Gentles A, Feng W, Xu Y . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015; 12(5):453-7. PMC: 4739640. DOI: 10.1038/nmeth.3337. View

van Wijnen A, Bagheri L, Badreldin A, Larson A, Dudakovic A, Thaler R . Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development. Bone. 2020; 143:115659. DOI: 10.1016/j.bone.2020.115659. View

Goldman M, Craft B, Hastie M, Repecka K, McDade F, Kamath A . Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020; 38(6):675-678. PMC: 7386072. DOI: 10.1038/s41587-020-0546-8. View

Lian G, Chen S, OuYang M, Li F, Chen L, Yang J . Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway. Technol Cancer Res Treat. 2019; 18:1533033819849068. PMC: 6535704. DOI: 10.1177/1533033819849068. View

Oshiro H, Hirabayashi Y, Furuta Y, Okabe S, Gotoh Y . Up-regulation of HP1γ expression during neuronal maturation promotes axonal and dendritic development in mouse embryonic neocortex. Genes Cells. 2014; 20(2):108-20. DOI: 10.1111/gtc.12205. View

Kent L, Leone G . The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019; 19(6):326-338. DOI: 10.1038/s41568-019-0143-7. View

Peng W, Shi S, Zhong J, Liang H, Hou J, Hu X . CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression. Oncogene. 2022; 41(22):3051-3063. DOI: 10.1038/s41388-022-02296-9. View

Hamid O, Robert C, Daud A, Hodi F, Hwu W, Kefford R . Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann Oncol. 2019; 30(4):582-588. PMC: 6503622. DOI: 10.1093/annonc/mdz011. View

10.

Nielsen A, Oulad-Abdelghani M, Ortiz J, Remboutsika E, Chambon P, Losson R . Heterochromatin formation in mammalian cells: interaction between histones and HP1 proteins. Mol Cell. 2001; 7(4):729-39. DOI: 10.1016/s1097-2765(01)00218-0. View

11.

Chang S, Lai Y, Chen Y, Wang N, Wang W, Lai J . CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer. Asia Pac J Clin Oncol. 2017; 14(5):e283-e288. DOI: 10.1111/ajco.12820. View

12.

Georgakilas A, Martin O, Bonner W . p21: A Two-Faced Genome Guardian. Trends Mol Med. 2017; 23(4):310-319. DOI: 10.1016/j.molmed.2017.02.001. View

13.

Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N . European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022; 170:236-255. DOI: 10.1016/j.ejca.2022.03.008. View

14.

Liang H, Yang C, Zeng R, Song Y, Wang J, Xiong W . Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer. Adv Sci (Weinh). 2023; 10(36):e2302368. PMC: 10754129. DOI: 10.1002/advs.202302368. View

15.

Zhang H, Yu H, Ren D, Sun Y, Guo F, Cai H . CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression. Int J Biol Sci. 2022; 18(8):3484-3497. PMC: 9134897. DOI: 10.7150/ijbs.68995. View

16.

Rubin S, Sage J, Skotheim J . Integrating Old and New Paradigms of G1/S Control. Mol Cell. 2020; 80(2):183-192. PMC: 7582788. DOI: 10.1016/j.molcel.2020.08.020. View

17.

Engeland K . Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022; 29(5):946-960. PMC: 9090780. DOI: 10.1038/s41418-022-00988-z. View

18.

Oyama K, El-Nachef D, Fang C, Kajimoto H, Brown J, Singh P . Deletion of HP1γ in cardiac myocytes affects H4K20me3 levels but does not impact cardiac growth. Epigenetics Chromatin. 2018; 11(1):18. PMC: 5905015. DOI: 10.1186/s13072-018-0187-z. View

19.

Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J . LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell Death Dis. 2020; 11(12):1032. PMC: 7710718. DOI: 10.1038/s41419-020-03247-6. View

20.

Yi S, Lee D, Kim G, Ryu H, Park J, Lee J . HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53. Cell Death Differ. 2020; 27(9):2537-2551. PMC: 7429875. DOI: 10.1038/s41418-020-0520-5. View